Digital quantitative assessment of PD-L1 using digital spatial profiling

The assessment of programmed death 1 ligand 1 (PD-L1) expression by Immunohistochemistry (IHC) is the US Food and Drug Administration (FDA)-approved predictive marker to select responders to checkpoint blockade anti-PD-1/PD-L1 axis immunotherapies. Different PD-L1 immunohistochemistry (IHC) assays u...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Swati, Zugazagoitia, Jon, Martinez-Morilla, Sandra, Fuhrman, Kit, Rimm, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502436/
https://www.ncbi.nlm.nih.gov/pubmed/32249818
http://dx.doi.org/10.1038/s41374-020-0424-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502436/
https://www.ncbi.nlm.nih.gov/pubmed/32249818
http://dx.doi.org/10.1038/s41374-020-0424-5

Ejemplares similares